Medical Consumables and Lab Consumables OEM Manufacturer
Medical Consumables and Lab Consumables OEM Manufacturer

News & Events

03 2022.11
Academician Zhang Dan of Hillgene Was Invited to Attend and Make His Presentation at the 22nd Taihu Economic and Trade Cooperation Meeting of Wuzhong District
On November 1, the 2022 Suzhou Wuzhong (22nd) Taihu Economic and Trade Cooperation Fair was held on the banks of the beautiful Taihu Lake. Academician Zhang Dan, foreign academician of the Russian Aca...
03 2022.11
Congratulations!! Released Globally! ICH Guideline E19, with Academician Zhang Dan as a Working Expert, Was Formally Released and Reached Step 5
According to the ICH official website, ICH Guideline E19 has entered the Step 5 stage of full implementation by ICH members. Academician Zhang Dan, Vice Chairman of Spectrum Biopharma, participated in...
03 2022.11
Big News: Newly released “Good Manufacturing Practice for Cellular Therapy Products (Interim)”!
On October 31, 2022, in order to guide the drug MAH to standardize the production and quality management of cell therapy products, the National Bureau Verification Center issued the "Guidelines f...
03 2022.11
Breaking | Hillgene Was Accepted as a Candidate of the “Unicorn” Enterprises Fostering Program
Science and technology are the primary productive forces. National and regional development cannot be separated from scientific and technological innovation. In order to implement the innovation-drive...
17 2022.10
Big News: FDA issued the finalized version of guidance “Comparability Protocols for Post-approval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA”
Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA (October 2022)On October 13, 2022, the FDA (CDER and CBER) issued the...
13 2022.09
Hillgene Won the BioCon Awards [Annual CDMO Excellence Award]
On September 6, BioCon Expo 2022, the 9th International Biopharmaceutical Conference and Exhibition, was held as scheduled at the Hangzhou International Expo Center. The BioCon Awards Ceremony and the...
15 2022.08
Hillgene Was Awarded the TOP 10 Most Promising CXO Companies of [China Biopharmaceutical Industry in 2022]
On August 4-5, the 6th Biomedical Innovation Cooperation Conference and the 2022 China Biomedical Industry Value List Awards Ceremony were held at the Kempinski Hotel Suzhou Jinji Lake. The conference...
15 2022.08
MAH System Stimulates the Vitality of Innovation - Hillgene Empowers the Cellular Therapy Products with CQDMO Services
On July 22-23, 2022, the first International MAH (Marketing Authorization Holder) Cooperation and Innovation Summit was held in Hangzhou.This conference focused on the MAH system, and centered around ...
15 2022.08
Hillgene Reached a Strategic Cooperation with HighthinkMed in Exploring One-Stop Whole-Process Innovative Service Mode for Cellular Therapy Products
Recently, Jiangsu Specoxin Biopharmaceutical Co., Ltd. (hereinafter referred to as "Specoxin Biopharmaceutical") and Beijing Hekinge Pharmaceutical Technology Co., Ltd. (hereinafter referred...
19 2022.07
Innovative and Breakthrough CGT, Best Opportunity and Perfect Timing at Dongtai Hu Lake: CGT Industrialization Summit and First Anniversary Celebration of Hillgene
Innovation breaks through CGT, and the wind and clouds gather at East Taihu Lake! A year ago, Spectrum Bio and Tong Xieyi hosted the "East Taihu Cell and Gene Therapy Industrialization Developmen...
29 2022.06
Official Operation of Hillgene R&D Center, Boosting the Innovation of the Biopharmaceutical Industry in Wuzhong District
This morning (June 28), the ribbon-cutting ceremony for the official operation of Spectrum Biotechnology R&D Center was held. Gu Hongjian, member of the Party Working Committee and deputy director...
27 2022.06
Hillgene Reached a Strategic Cooperation with T-Maximum in Accelerating the innovation and Breakthrough of Universal Cells
Recently, Jiangsu Puxin Biopharmaceutical Co., Ltd. (hereinafter referred to as "Puxin Biopharmaceutical") and Maoxing Biopharmaceutical Technology Co., Ltd. (hereinafter referred to as &quo...